ArticleJournal of clinical medicine2026

Macrocytosis as an Early Pharmacodynamic Marker of Imatinib Efficacy in Chronic Myeloid Leukemia.

Fatih Yaman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.